Santhera Pharmaceuticals Holding AG (SWX:SANN)
Switzerland flag Switzerland · Delayed Price · Currency is CHF
16.00
-0.34 (-2.08%)
Feb 20, 2026, 5:31 PM CET

SWX:SANN Ratios and Metrics

Millions CHF. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
22816790755654
Market Cap Growth
10.88%85.24%19.92%34.92%3.51%-57.20%
Enterprise Value
2501771301039196
Last Close Price
16.3413.829.8113.8013.3028.00
PE Ratio
--1.65---
PS Ratio
4.644.280.8710.08-35.003.59
PB Ratio
-88.796.041.51-1.7242.04-8.49
P/FCF Ratio
--1.91---
P/OCF Ratio
--1.91---
EV/Sales Ratio
5.114.531.2613.82-6.41
EV/EBITDA Ratio
--2.42---
EV/EBIT Ratio
--2.54---
EV/FCF Ratio
-6.10-2.76---
Debt / Equity Ratio
-16.081.470.36-1.0232.36-11.20
Debt / EBITDA Ratio
--0.40---
Debt / FCF Ratio
--0.46---
Net Debt / Equity Ratio
-8.91-0.01-0.15-0.9916.39-9.25
Net Debt / EBITDA Ratio
-0.500.01-0.16-1.01-0.41-1.18
Net Debt / FCF Ratio
-0.560.01-0.19-1.44-0.58-1.35
Asset Turnover
0.410.301.190.10-0.15
Inventory Turnover
2.651.613.3713.408.292.84
Quick Ratio
0.511.190.710.050.710.58
Current Ratio
1.021.640.760.060.750.61
Return on Equity (ROE)
-288.14%-95.79%673.95%---908.60%
Return on Assets (ROA)
-26.60%-15.81%36.89%-36.95%-39.55%-32.56%
Return on Invested Capital (ROIC)
-250.98%-84.45%202.40%-406.92%-150.70%-103.78%
Return on Capital Employed (ROCE)
-69.70%-31.20%80.10%-319.80%-97.50%-89.00%
Earnings Yield
-28.80%-25.09%60.65%-94.37%-99.47%-125.46%
FCF Yield
-18.05%-21.32%52.24%-39.69%-66.92%-80.73%
Buyback Yield / Dilution
-9.97%-4.24%-79.29%-78.31%-156.61%-21.15%
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.